Hey there, web surfer!

To search and monitor rising trends,
create an account here. It's free.

Join Treendly

live demand report in US

Biib Stock

Finance     

  

Track this trend
(Monitor this trend over time)
 12 Months
Trend: declining
MOM change: -0.14%
 5 Years
Trend: growing
MOM change: 0.34%

Latest forum discussions

We tracked 48 total in the last 3 months

...,515 units of Biogen Inc stock worth over $256,976,183... last 19 years he sold BIIB stock worth over $7,886,746...,515 units of Biogen Inc stock worth over $256,976,183... last 19 years he sold BIIB stock worth over $7,886,746...
Published on 2022-08-29 in the RGLS forum
This discussion is in English.
The HFs backing BIIB are the same ones shorting SAVA who is about to release best in class OL data. Talk about doubling down on a losing bet. Just because coordinating HFs have enough capital to move stock prices, it does not change the performance and safety facts about the two drugs. People are going to buy and take SAVA's drug, they won't touch BIIB's.
Published on 2022-10-11 in the Biogen Inc. (BIIB) forum
This discussion is in English.
The HFs backing BIIB are the same ones shorting SAVA who is about to release best in class OL data. Talk about doubling down on a losing bet. Just because coordinating HFs have enough capital to move stock prices, it does not change the performance and safety facts about the two drugs. People are going to buy and take SAVA's drug, they won't touch BIIB's.
Published on 2022-10-11 in the Biogen Inc. (BIIB) forum
This discussion is in English.
... Alzheimer's treatment." Biogen (ticker: BIIB) and Eisai (ESALY) announced late... the highest close for the stock since November 2021, according to ...Dow Jones Market Data. The stock has now climbed 15% this ..., but remained Neutral on the stock with a $190 price target. ... range, and we expect the stock could be about 50% up ... looks unequivocal." Abrahams rates the stock at Outperform and raised his ...
Published on 2022-09-28 in the BIIB forum
This discussion is in English.
... Alzheimer's treatment." Biogen (ticker: BIIB) and Eisai (ESALY) announced late... the highest close for the stock since November 2021, according to ...Dow Jones Market Data. The stock has now climbed 15% this ..., but remained Neutral on the stock with a $190 price target. ... range, and we expect the stock could be about 50% up ... looks unequivocal." Abrahams rates the stock at Outperform and raised his ...
Published on 2022-09-28 in the BIIB forum
This discussion is in English.
Biogen Lifts Profit Estimates. The Stock Rises. Vanjani, Karishma.ā€‰ Barron's (... Eisai (ticker: ESALY) and Biogen (BIIB) last month said the Phase ... upper end expected previously. The stock climbed 1.4% to $278....
Published on 2022-10-25 in the BIIB forum
This discussion is in English.
Biogen Lifts Profit Estimates. The Stock Rises. Vanjani, Karishma.ā€‰ Barron's (... Eisai (ticker: ESALY) and Biogen (BIIB) last month said the Phase ... upper end expected previously. The stock climbed 1.4% to $278....
Published on 2022-10-25 in the BIIB forum
This discussion is in English.
... note that extends beyond the stock market, shares of Biogen (BIIB) have soared nearly 50% following... decidedly positive news, as the stock's response suggests, and we ... chance to lead AD market (BIIB) Biogen (BIIB) is skyrocketing higher and generating ... with Eisai. That obviously limits BIIB's profit potential, but the ... be a game-changer for BIIB and for those suffering from ...
Published on 2022-09-28 in the Techstocks forum
This discussion is in English.
... note that extends beyond the stock market, shares of Biogen (BIIB) have soared nearly 50% following... decidedly positive news, as the stock's response suggests, and we ... chance to lead AD market (BIIB) Biogen (BIIB) is skyrocketing higher and generating ... with Eisai. That obviously limits BIIB's profit potential, but the ... be a game-changer for BIIB and for those suffering from ...
Published on 2022-09-28 in the Techstocks forum
This discussion is in English.
..., on Wednesday. HIGHLIGHTS * Biogen Inc BIIB.O : Baird raises to outperform... reported by Reuters on Wednesday. Stock entries are in alphabetical order...$31 from $30 * Biogen Inc BIIB.O : Baird raises to outperform...from market perform * Biogen Inc BIIB.O : Mizuho raises to buy...$270 from $207 * Biogen Inc BIIB.O : Piper Sandler raises target...$321 from $251 * Biogen Inc BIIB.O : Wedbush raises target price...
Published on 2022-09-28 in the Canadian Blue-chip Industrial Forum forum
This discussion is in English.
..., on Wednesday. HIGHLIGHTS * Biogen Inc BIIB.O : Baird raises to outperform... reported by Reuters on Wednesday. Stock entries are in alphabetical order...$31 from $30 * Biogen Inc BIIB.O : Baird raises to outperform...from market perform * Biogen Inc BIIB.O : Mizuho raises to buy...$270 from $207 * Biogen Inc BIIB.O : Piper Sandler raises target...$321 from $251 * Biogen Inc BIIB.O : Wedbush raises target price...
Published on 2022-09-28 in the Canadian Blue-chip Industrial Forum forum
This discussion is in English.
...:43 AM ET Biogen Inc. (BIIB) RHHBY, LLY, SAVA, ESALY,...via Getty Images Biogen (NASDAQ: BIIB) and Japanese drugmaker Eisai ( OTCPK... FDA-approved mediation that Biogen ( BIIB) and Eisai ( OTCPK:ESALF) ... its clinical benefit. While Biogen ( BIIB) has added ~40%, Eisai (...~17% higher on the Tokyo Stock Exchange. The "study results prove...prompted Baird to upgrade Biogen ( BIIB) to Outperform from Neutral. ...
Published on 2022-09-28 in the Biotech forum
This discussion is in English.
...:43 AM ET Biogen Inc. (BIIB) RHHBY, LLY, SAVA, ESALY,...via Getty Images Biogen (NASDAQ: BIIB) and Japanese drugmaker Eisai ( OTCPK... FDA-approved mediation that Biogen ( BIIB) and Eisai ( OTCPK:ESALF) ... its clinical benefit. While Biogen ( BIIB) has added ~40%, Eisai (...~17% higher on the Tokyo Stock Exchange. The "study results prove...prompted Baird to upgrade Biogen ( BIIB) to Outperform from Neutral. ...
Published on 2022-09-28 in the Biotech forum
This discussion is in English.
..., on Wednesday. HIGHLIGHTS * Biogen Inc BIIB.O : SVB Securities raises target... reported by Reuters on Wednesday. Stock entries are in alphabetical order... $155 from $160 * Biogen Inc BIIB.O : Cowen and Company raises... $300 from $270 * Biogen Inc BIIB.O : RBC raises target price... $331 from $310 * Biogen Inc BIIB.O : SVB Securities raises target...$310 from $270 * Biogen, Inc BIIB.O : H.C. Wainwright raises...
Published on 2022-10-26 in the Canadian Blue-chip Industrial Forum forum
This discussion is in English.
..., on Wednesday. HIGHLIGHTS * Biogen Inc BIIB.O : SVB Securities raises target... reported by Reuters on Wednesday. Stock entries are in alphabetical order... $155 from $160 * Biogen Inc BIIB.O : Cowen and Company raises... $300 from $270 * Biogen Inc BIIB.O : RBC raises target price... $331 from $310 * Biogen Inc BIIB.O : SVB Securities raises target...$310 from $270 * Biogen, Inc BIIB.O : H.C. Wainwright raises...
Published on 2022-10-26 in the Canadian Blue-chip Industrial Forum forum
This discussion is in English.
... reported by Reuters on Tuesday. Stock entries are in alphabetical order... ACVA.O : JP Morgan removes stock from its analyst focus list... Morgan adds stock to its analyst focus list * Biogen Inc BIIB.O... BOOT.N : JP Morgan removes stock from its analyst focus list... FRC.N : JP Morgan removes stock from its analyst focus list...
Published on 2022-11-01 in the Canadian Blue-chip Industrial Forum forum
This discussion is in English.
... reported by Reuters on Tuesday. Stock entries are in alphabetical order... ACVA.O : JP Morgan removes stock from its analyst focus list... Morgan adds stock to its analyst focus list * Biogen Inc BIIB.O... BOOT.N : JP Morgan removes stock from its analyst focus list... FRC.N : JP Morgan removes stock from its analyst focus list...
Published on 2022-11-01 in the Canadian Blue-chip Industrial Forum forum
This discussion is in English.
... late-stage trial Biogen (NASDAQ:BIIB) and Japanese drugmaker Eisai (OTCPK... FDA-approved mediation that Biogen (BIIB) and Eisai (OTCPK:ESALF) developed... its clinical benefit. While Biogen (BIIB) has added ~40%, Eisai (OTCPK... ~17% higher on the Tokyo Stock Exchange. The "study results prove... prompted Baird to upgrade Biogen (BIIB) to Outperform from Neutral. Noting...
Published on 2022-09-28 in the Agenus Inc. (AGEN) forum
This discussion is in English.
... late-stage trial Biogen (NASDAQ:BIIB) and Japanese drugmaker Eisai (OTCPK... FDA-approved mediation that Biogen (BIIB) and Eisai (OTCPK:ESALF) developed... its clinical benefit. While Biogen (BIIB) has added ~40%, Eisai (OTCPK... ~17% higher on the Tokyo Stock Exchange. The "study results prove... prompted Baird to upgrade Biogen (BIIB) to Outperform from Neutral. Noting...
Published on 2022-09-28 in the Agenus Inc. (AGEN) forum
This discussion is in English.